Rejuvenating premature aging.
Meshorer
Eran
E
Gruenbaum
Yosef
Y
D000818:Animals; D050071:Bone Density Conservation Agents / Q000494:pharmacology*; D002467:Cell Nucleus / Q000187:drug effects; D004164:Diphosphonates / Q000494:pharmacology*; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D051231:Farnesyltranstransferase / Q000037:antagonists & inhibitors; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D034904:Lamin Type A; D008136:Longevity / Q000187:drug effects; D051379:Mice; D018345:Mice, Knockout; D009687:Nuclear Proteins / Q000378:metabolism; D017035:Pravastatin / Q000494:pharmacology*; D054876:Prenylation / Q000187:drug effects; D011371:Progeria / Q000188:drug therapy* / Q000235:genetics; D011498:Protein Precursors / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007093:Imidazoles; D034904:Lamin Type A; D009687:Nuclear Proteins; D011498:Protein Precursors; D016159:Tumor Suppressor Protein p53; C090764:prelamin A; D000077211:Zoledronic Acid; D051231:Farnesyltranstransferase; D017035:Pravastatin